company background image
AWH

Aspira Women's Health NasdaqCM:AWH Stock Report

Last Price

US$0.95

Market Cap

US$106.7m

7D

-2.1%

1Y

-74.3%

Updated

17 Aug, 2022

Data

Company Financials +
AWH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

AWH Stock Overview

Aspira Women’s Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States.

Aspira Women's Health Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aspira Women's Health
Historical stock prices
Current Share PriceUS$0.95
52 Week HighUS$3.92
52 Week LowUS$0.32
Beta2.79
1 Month Change2.99%
3 Month Change72.70%
1 Year Change-74.26%
3 Year Change72.73%
5 Year Change-24.00%
Change since IPO-99.70%

Recent News & Updates

Aug 10

Aspira Women’s Health GAAP EPS of -$0.07 in-line, revenue of $2.06M misses by $0.34M

Aspira Women’s Health press release (NASDAQ:AWH): Q2 GAAP EPS of -$0.07 in-line. Revenue of $2.06M (+14.4% Y/Y) misses by $0.34M.

Aug 02
Is Aspira Women's Health (NASDAQ:AWH) Using Too Much Debt?

Is Aspira Women's Health (NASDAQ:AWH) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Shareholder Returns

AWHUS Medical EquipmentUS Market
7D-2.1%-0.4%1.1%
1Y-74.3%-21.1%-9.0%

Return vs Industry: AWH underperformed the US Medical Equipment industry which returned -20.7% over the past year.

Return vs Market: AWH underperformed the US Market which returned -8.9% over the past year.

Price Volatility

Is AWH's price volatile compared to industry and market?
AWH volatility
AWH Average Weekly Movement21.2%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.6%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: AWH is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 21% a week.

Volatility Over Time: AWH's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1993107Nicole Sandfordhttps://aspirawh.com

Aspira Women’s Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer.

Aspira Women's Health Fundamentals Summary

How do Aspira Women's Health's earnings and revenue compare to its market cap?
AWH fundamental statistics
Market CapUS$106.68m
Earnings (TTM)-US$36.18m
Revenue (TTM)US$7.48m

14.3x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AWH income statement (TTM)
RevenueUS$7.48m
Cost of RevenueUS$3.79m
Gross ProfitUS$3.69m
Other ExpensesUS$39.87m
Earnings-US$36.18m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.32
Gross Margin49.36%
Net Profit Margin-483.93%
Debt/Equity Ratio21.8%

How did AWH perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is AWH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AWH?

Other financial metrics that can be useful for relative valuation.

AWH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue12x
Enterprise Value/EBITDA-2.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does AWH's PS Ratio compare to its peers?

AWH PS Ratio vs Peers
The above table shows the PS ratio for AWH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average8.5x
CTSO Cytosorbents
2.1x31.6%US$78.4m
FONR FONAR
1xn/aUS$101.8m
KRMD KORU Medical Systems
4.4x11.7%US$112.6m
HYPR Hyperfine
26.5x42.1%US$101.8m
AWH Aspira Women's Health
14.3x41.7%US$106.7m

Price-To-Sales vs Peers: AWH is expensive based on its Price-To-Sales Ratio (14.3x) compared to the peer average (8.5x).


Price to Earnings Ratio vs Industry

How does AWH's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Sales vs Industry: AWH is expensive based on its Price-To-Sales Ratio (14.3x) compared to the US Medical Equipment industry average (4.5x)


Price to Sales Ratio vs Fair Ratio

What is AWH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AWH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio14.3x
Fair PS Ratio6.9x

Price-To-Sales vs Fair Ratio: AWH is expensive based on its Price-To-Sales Ratio (14.3x) compared to the estimated Fair Price-To-Sales Ratio (6.9x).


Share Price vs Fair Value

What is the Fair Price of AWH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AWH ($0.95) is trading below our estimate of fair value ($4.24)

Significantly Below Fair Value: AWH is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Aspira Women's Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


4.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AWH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AWH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AWH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AWH's revenue (41.7% per year) is forecast to grow faster than the US market (7.9% per year).

High Growth Revenue: AWH's revenue (41.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AWH's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Aspira Women's Health performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-25.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AWH is currently unprofitable.

Growing Profit Margin: AWH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AWH is unprofitable, and losses have increased over the past 5 years at a rate of 25.9% per year.

Accelerating Growth: Unable to compare AWH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AWH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).


Return on Equity

High ROE: AWH has a negative Return on Equity (-256.19%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Aspira Women's Health's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: AWH's short term assets ($23.0M) exceed its short term liabilities ($7.0M).

Long Term Liabilities: AWH's short term assets ($23.0M) exceed its long term liabilities ($2.9M).


Debt to Equity History and Analysis

Debt Level: AWH has more cash than its total debt.

Reducing Debt: AWH's debt to equity ratio has reduced from 37.1% to 21.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AWH has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: AWH has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 16.1% each year.


Discover healthy companies

Dividend

What is Aspira Women's Health current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate AWH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AWH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AWH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AWH's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AWH has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure


CEO

Nicole Sandford (52 yo)

0.42yr

Tenure

US$147,250

Compensation

Ms. Nicole Sandford, C.P.A., serves as President, Chief Executive Officer since March 1, 2022 and served as its Director at Aspira Women's Health Inc. since March 1, 2022 until July 2022. She had been Inde...


Leadership Team

Experienced Management: AWH's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: AWH's board of directors are considered experienced (7.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Aspira Women's Health Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Aspira Women's Health Inc.
  • Ticker: AWH
  • Exchange: NasdaqCM
  • Founded: 1993
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$106.682m
  • Shares outstanding: 112.30m
  • Website: https://aspirawh.com

Number of Employees


Location

  • Aspira Women's Health Inc.
  • Building III
  • Suite 100
  • Austin
  • Texas
  • 78738
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/17 00:00
End of Day Share Price2022/08/17 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.